Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyChristopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2022
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancerTiuri E Kroese, Peter S N van Rossum, Magnus Nilsson, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2021
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiationFinbar Slevin, Katharine Aitken, Filippo Alongi, et al.
Practical Radiation Oncology|January 20, 2024
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert ConsensusTed K Yanagihara, Joel E Tepper, Andrew M Moon, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Pageof 8